News

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced that its AC3 Range™ Intra-Aortic Balloon Pump (IABP) has received FDA 510(k) clearance. Designed for seamless intra-aortic balloon ...
IABP systems are typically inserted within the multidisciplinary environment that is the cardiac catheterization laboratory. The specific role of the physiologist during IABP insertion is to ...
Teleflex (TFX) announced FDA 510(k) clearance of the AC3 Range Intra-Aortic Balloon Pump. Leveraging the patented technology of the AC3 Optimus IABP, the AC3 Range IABP is designed to provide ...
Despite a revenue decline, Teleflex Inc (TFX) focuses on strategic initiatives and market expansion to drive future growth.
WAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra-Aortic ...
such as the intra-aortic balloon pump. Now some 40 years since its first-in-man description, the situations and strategies in which to utilize its attractive physiological properties are still ...
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra-Aortic Balloon Pump (IABP). Leveraging the ...